BDBM767414 2-[4-[[4-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)-2-pyridyl]-3-oxo- pyrazolo[3,4-d]pyrimidin-6- yl]piperazin-1-yl]methyl]phenyl]-6- fluoro-3,10- diazatricyclo[6.4.1.04,13]trideca- 1,4,6,8(13)-tetraen-9-one::US20250270212, Compound 44

SMILES C=CCNC(=O)c1cnc(N2CCN(Cc3ccc(-c4[nH]c5cc(F)cc6c5c4CCNC6=O)cc3)CC2)nc1Nc1cccc(C(C)(C)O)n1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 767414   

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767414(2-[4-[[4-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent